2m 2m 2m 2m 2m 2m 2m
NASUS PHARMA (NSRX)
NYSE
$4.12+$0.12 (+3.00%)
Price as of Aug 24, 2026 1:45 PM EDT- N/AMarket Cap
- -50.92%1-Year Change
- Drug Manufacturers - GeneralIndustry
NASUS PHARMA (NSRX)
$4.12+$0.12 (+3.00%)
Top Holders
Institutional
Mutual Funds
No data found
No data found
Current Ownership Distribution
- Other8.2M (94.89%)
- Insiders439,697 (5.11%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
Insider Transactions
- 5.11% (439,697)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $499,413.94Amount of InsiderBuying (last 12 months)
- 0Number of InsiderSelling (last 12 months)
- $0.00Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Teleman Dan Benjamin Chief Executive Officer | Buy | Jun 17, 2026 | $20,305.00 | 6,550 | $3.10 | 163,541 |
Teleman Dan Benjamin Chief Executive Officer | Buy | Mar 31, 2026 | $30,600.00 | 15,000 | $2.04 | 21,246 |